Stockscreener 앱 받기
1.82
2.25%
0.04
시간 외 거래:
1.80
-0.02
-1.10%
Stereotaxis Inc 주식(STXS)의 최신 뉴스
Stereotaxis director Isaac Paul acquires $68,780 in common stock By Investing.com - Investing.com South Africa
Director Makes Bold Move with Major Stereotaxis Stock Purchase - TipRanks
Stereotaxis director Isaac Paul acquires $68,780 in common stock - Investing.com
Stereotaxis director Paul Isaac acquires $44,836 in common stock By Investing.com - Investing.com Canada
Stereotaxis director Paul Isaac acquires $44,836 in common stock - Investing.com Australia
Stereotaxis to Present at 37th Annual Roth Conference - GlobeNewswire
Stereotaxis Stock Slides Despite MAGiC Sweep Catheter FDA Submission - Yahoo Finance
Stereotaxis To Get FDA Approval Of MAGiC This Fall, Ending Cash Burn (NYSE:STXS) - Seeking Alpha
Q1 Earnings Estimate for Stereotaxis Issued By Roth Capital - Defense World
Stereotaxis, Inc. (AMEX:STXS) Q4 2024 Earnings Call Transcript - MSN
Stereotaxis submits catheter pair for FDA clearance - Robot Report
STXS Stock Tumbles Despite EMAGIN Catheter Submission for Approval - MSN
Stereotaxis sees double digit revenue growth for FY25 - Yahoo Finance
Stereotaxis submits EMAGIN catheter for regulatory clearance - Yahoo Finance
Stereotaxis announces FDA regulatory submission for MAGiC Sweep catheter - Yahoo Finance
Stereotaxis Inc (STXS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... - Yahoo Finance
Stereotaxis Inc (STXS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... By GuruFocus - Investing.com Canada
Stereotaxis Earnings Call: Growth Amid Challenges - TipRanks
Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates - MSN
Stereotaxis earnings missed by $0.03, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: Stereotaxis Q4 2024 misses forecasts, stock dips By Investing.com - Investing.com Canada
Stereotaxis seeks FDA nod for robotic catheter system By Investing.com - Investing.com Canada
Stereotaxis seeks FDA nod for robotic catheter - Investing.com India
Stereotaxis seeks FDA nod for robotic catheter system - Investing.com India
Stereotaxis seeks FDA nod for robotic catheter By Investing.com - Investing.com South Africa
Stereotaxis Inc Reports Q4 2024 Earnings: EPS of -$0.09 Misses E - GuruFocus.com
Stereotaxis Reports 2024 Full Year Financial Results - The Manila Times
Stereotaxis Submits FDA Application for EMAGIN™ 5F, First Robotically Navigated Catheter for Endovascular Procedures - Nasdaq
Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance - GlobeNewswire
Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery - GlobeNewswire
Can Stereotaxis Revolutionize Stroke and Cancer Treatment? New Robotic Catheter Heads to FDA - StockTitan
Could This First-Ever Robotic Mapping Catheter Transform Cardiac Procedures? - StockTitan
Can Stereotaxis Turn Q4 Momentum Into Sustained Growth After Flat 2024 Results? - StockTitan
Stereotaxis Reports Strong Revenue Growth and Strategic Milestones - TipRanks
Stereotaxis, Inc. to Host Earnings Call - ACCESS Newswire
Stereotaxis (STXS) to Release Quarterly Earnings on Monday - Defense World
Stereotaxis Inc (STXS) Q4 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Stereotaxis Inc (STXS) Q4 2024: Everything You Need To Know Ahea - GuruFocus.com
Stereotaxis (STXS) Projected to Post Quarterly Earnings on Monday - MarketBeat
Stereotaxis to Present at 45th Annual TD Cowen Healthcare Conference - GlobeNewswire
Global Magnetic Ablation Catheters Market Poised for Significant Growth, Projected to Reach USD 1,114.4 Million by 2035 Driven by Technological Advancements and Rising Cardiovascular Cases | Future Market Insights, Inc. - GlobeNewswire Inc.
Legato Capital Management LLC Sells 111,859 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) - MarketBeat
Stock Market Sleeps On Stereotaxis MAGiC CE Mark (NYSE:STXS) - Seeking Alpha
SG Americas Securities LLC Has $60,000 Holdings in Stereotaxis, Inc. (NYSEAMERICAN:STXS) - Defense World
STXS Stock Gains Following the First Order for its GenesisX - MSN
Stereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 - GlobeNewswire
3.54%
자본화:
|
볼륨(24시간):